EUVD-2024-52365

Comprehensive Technical Analysis of EUVD-2024-52365

1. Vulnerability Assessment and Severity Evaluation

Vulnerability Description: The vulnerability in question is a Missing Authorization flaw in the dugudlabs Eyewear prescription form, which allows for Privilege Escalation. This issue affects versions from n/a through 4.0.18.

Severity Evaluation: The Base Score of 9.8 (CVSS:3.1) indicates a critical vulnerability. The CVSS vector CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H breaks down as follows:

• Attack Vector (AV:N): Network, meaning the vulnerability is exploitable over the network.
• Attack Complexity (AC:L): Low, indicating that the attack is relatively straightforward.
• Privileges Required (PR:N): None, meaning no special privileges are needed to exploit the vulnerability.
• User Interaction (UI:N): None, indicating that no user interaction is required.
• Scope (S:U): Unchanged, meaning the vulnerability does not affect other security scopes.
• Confidentiality (C:H), Integrity (I:H), Availability (A:H): All high, indicating significant impact on all three security properties.

2. Potential Attack Vectors and Exploitation Methods

Attack Vectors:

• Network-Based Attacks: Given the CVSS vector, attackers can exploit this vulnerability over the network without needing physical access or user interaction.
• Privilege Escalation: The primary attack vector involves exploiting the missing authorization to escalate privileges, potentially gaining administrative access.

Exploitation Methods:

• Arbitrary Option Update: Attackers can update arbitrary options in the Eyewear prescription form, leading to privilege escalation.
• Unauthorized Access: By exploiting the missing authorization, attackers can access and modify sensitive data, leading to further compromise.

3. Affected Systems and Software Versions

Affected Software:

• Product: Eyewear prescription form
• Vendor: dugudlabs
• Versions: n/a through 4.0.18

Systems:

• Any system running the affected versions of the Eyewear prescription form, particularly those integrated with WordPress.

4. Recommended Mitigation Strategies

Immediate Actions:

• Patching: Upgrade to a patched version of the Eyewear prescription form if available.
• Temporary Mitigation: Disable the Eyewear prescription form plugin until a patch is released.

Long-Term Mitigation:

• Regular Updates: Ensure all plugins and software are regularly updated.
• Access Controls: Implement strict access controls and authorization checks.
• Monitoring: Continuously monitor for suspicious activities and unauthorized access attempts.

5. Impact on European Cybersecurity Landscape

Regulatory Compliance:

• GDPR: The vulnerability could lead to unauthorized access to personal data, potentially violating GDPR regulations.
• NIS Directive: Organizations in critical sectors must ensure robust cybersecurity measures, and this vulnerability could impact compliance.

Economic Impact:

• Financial Loss: Potential data breaches could result in financial losses due to fines, legal actions, and loss of customer trust.
• Operational Disruption: Compromised systems could lead to operational disruptions, affecting business continuity.

6. Technical Details for Security Professionals

Vulnerability Details:

• CVE ID: CVE-2024-54239
• Assigner: Patchstack
• References: Patchstack Vulnerability Report

Technical Recommendations:

• Code Review: Conduct a thorough code review of the Eyewear prescription form to identify and fix missing authorization checks.
• Security Audits: Regularly perform security audits to identify and mitigate similar vulnerabilities.
• Intrusion Detection: Implement intrusion detection systems (IDS) to monitor for unauthorized access attempts.

Conclusion: The Missing Authorization vulnerability in the dugudlabs Eyewear prescription form is critical and requires immediate attention. Organizations should prioritize patching and implementing robust security measures to mitigate the risk. Continuous monitoring and regular updates are essential to maintain a secure cybersecurity posture.